ACV deal gets hit with a shareholder probe

Deal drama, now with lawyers

ACV Auctions just added a new co-star to its sale process: a shareholder investigation. Brodsky & Smith says it’s looking into whether ACV’s board breached fiduciary duties in agreeing to sell the company to Copart for $10.50 per share in cash, a deal that implies about $1.9 billion in equity value.

Why investors should care

This isn’t just legal fine print for the nearest filing cabinet. Shareholder investigations can stir up publicity, invite lawsuits, and make a clean M&A closing a little less clean. In plain English: if shareholders think the board sold too cheaply or ran a sloppy process, they may try to squeeze more value out of the deal.

For Copart, the risk is mostly about deal friction, not existential drama. But any extra legal noise can slow timelines, add costs, or create a bigger question mark around whether the transaction will close exactly as planned.

The bigger picture

• ACV is the target here, but Copart is the buyer sitting in the splash zone.
• The headline deal is still $10.50 a share in cash.
• The core complaint: did ACV’s board run a fair process and get fair value?

Big picture: when a takeover starts attracting shareholder lawyers before the confetti even settles, you know the “all-cash certainty” pitch just got a little less certain.